本篇文章孕途国际给大家谈谈浙江中医院做试管感染艾滋，以及浙江试管婴儿hiv感染对应的知识点，希望对各位有所帮助，不要忘了收藏本站喔。

本文目录一览：

感染了艾滋病，还可以做试管婴儿吗？

感染HIV浙江中医院做试管感染艾滋，首先要看病毒载量和CD4数值，泰国试管都会对精子做前期处理，就是洗精术。是可以通过洗精后试管得到健康浙江中医院做试管感染艾滋的孩子的。

浙江中医院违规操作致5名患者被感染艾滋，你怎么看？

舞茸β-葡聚糖对HIV（艾滋病）病人的效果

Effects of Maitake (Grifola frondosa) gulcan in HIV-infected patients

【摘要翻译】

    为评估一种从舞茸中提取的β-葡聚糖MD-Fraction（舞茸D-fraction）对艾滋病（HIV）感染病人的效果，进行了长期的实验。参与实验的HIV感染者被跟踪监测CD4+ 细胞计数，病毒载量，艾滋病感染症状，继发病状况，以及健康状态。20位患者的CD4+细胞计数增加到原来的1.4-1.8倍，8位患者降低到原来的0.8-0.5倍。9位病人的病毒载量增加，10位降低。尽管如此，85%的受试者对于HIV引起的症状和继发病的感觉变好，这表明舞茸D-fraction对于艾滋病HIV患者具有积极的影响。

关键词： 抗HIV活性，CD4+细胞，舞茸，IL-2，MD-Fraction

注：CD4+细胞是人体免疫系统中的一种重要免疫细胞，由于艾滋病病毒攻击对象是CD4+细胞，所以其检测结果对艾滋病治疗效果的判断和对患者免疫功能的判断有重要作用。

【论文原文】

        Effects of Maitake (Grifola frondosa) gulcan in HIV-infected patients

Hiroaki Nanba1)*, Noriko Kodama1), Douglas Schar 2) and Denise Turner 2)

1)Department of Microbial Chemistry, Kobe Pharmaceutical University, 4-19-1,

Motoyamakita-machi, Higashinada-ku, kobe 658-8558, Japan

2)Herbal Clinical Research, 140 Columbia Road, London E2 7RG, U.K.

The effects of MD-Fraction, a β-glucan extracted from Maitake mushroom (Grifola frondosa)， on the health status of individuals suffering from HIV infection were evaluated in a long-term trial. The HIV status of the 35 respondents who participated in the study was followed by monitoring CD4+ cell counts, viral load measure, sympotoms of HIV infection, status of secondary disease, and sense of well-being. Twenty patients reported to increase in CD4+ cell counts to 1.4-1.8 times, and 8 patients reported a decrease to 0.8-0.5 times. Viral load was reported to increase in 9 patients and decrease in 10 patients. However, 85% of respondents reported an increased sense of well-being with regard to various symptoms and secondary diseases caused by HIV. These results suggest that Maitake D-Fraction had a positive impact in HIV patients.

Key Words : anti-HIV activity; CD4+ cell; Grifola frondosa (Maitake); IL-2; MD-Fraction

Acquired immune deficiency syndrome (AIDS) is caused by HIV infection, which attacks helper T cells (CD4+ cells) and decreases the body’s immunity. In 1991, we studied the effect of a Grifola frondosa S.F. Gray (Maitake) extract, named MD-Fraction on HIV, which is believed to be a cause of AIDS. Sulfated MD-Fraction was found to prevent HIV from killing helper T (CD4+) cells: almost 100% of CD4+ cells survived challenge by HIV at concentrations of sulfated MD-Fraction of around 1 pg/ml, and the results were presented in an abstract paper at the 8th International AIDS conference in Amsterdam in July 1992. National Institute of Health and National Cancer Institute in U.S.A. also confirmed the anti-HIV activity of the sulfated form of MD-Fraction. NCI doctors have recognized that the sulfated MD-Fraction is the most effective among all anti-HIV polysaccharides known to date and is as powerful as the drug azidothymidine (AZT). However, the sulfated MD-Fraction has the strong side-effect of toxicity to cells in vivo. On the other hand, we have reported that a β1,6-glucan having a β 1,3-branched chain (named MD-Fraction) can enhance immunocompent cell activities (Hishida et al., 1988; Nanba et al., 1987; Nanba et al., 1993).In this paper, we report that Maitake appears to work on several levels in HIV conditions, by (a) direct inhibition of the human immunodeficiency virus (HIV), (b) stimulation of the body’s own natural defense system against HIV, and (c) making the body less vulnerable to opportunistic disease.

Materials and Methods：

Preparation of Maitake tablets  Tablets containing 250 mg of dried Maitake powder(φ200 μm) and 5 mg of vitamin C were prepared with a tabloid machine.Preparation of MD-Fraction  Dried Maitake powder (500 g) was autclaved with 3,000 ml of distilled water at 120℃ for 60 min, and the water-soluble layer obtained was saturated with the same volume of ethanol at 4℃ for 12 h. After removal of floating material, this ethanol solution was saturated to 80% with ethanol and stored at 4℃ for 10 h. The pellet obtained by centrifugation at 5,000×g for 20 min was suspended in a small volume of distilled water and protein was removed by passage through a DEAE-cellulofine column (4×80cm). Finally 1 g of purified MD-Fraction was prepared.

Detection of virions  The HIV genome is known to have nine genes, three expressing structural protein and six expressing regulating protein. Anti-HIV-Env antibody was produced in blood from 10 wk to 12 yr after HIV infection. The coagulation test of antigen was performed with HIV-Env antibody collected from blood. Viral loads were counted in 50-μl portions of patients’ serum.Detection of interleukin-2 (IL-2)  Production of IL-2 in blood was detected with IL-2 ELISA Kit Intertest-2X (Genzyme Co. U.S.A.)Counting of CD4+ cells and CD8+ cells  CD4+ cells were counted by flow cytometric analysis after treatment of 10 μl of blood with CD4+- monoclonal antibody (Cytovax Biotechologies Inc.) The count of CD8+ cells was obtained by subtracting the CD4+ cell count from the total count of T cells determined by flow cytometric analysis.

Administration of Maitake  A supply of Maitake was given to each HIV carrier at a dose level of 6 g of tablets or 20mg of purified MD-Fraction together with 4 g of tablets per day for 360d.

Results：

The main focus in monitoring the progress of HIV disease is CD4+ cells (helper T cells). The normal range of CD4+ cell count is 500-1,200 cells/10μl of blood. A level of 200-500 cells indicates that some damage has occured. Below 200 cells, the individual is highly susceptible to secondary diseases. An elevated viral load indicates an increased risk of damage to CD4+ cells. The significance of these activities in regard to HIV infection relates to the immune system. Both IL-2 and interferon are activated by the immune system response to infection by viral disease. After administration of Maitake tablets for 12 mo to 35 respondents (24 in England and 11 in U.S.A.), 20 responders reported an increase in CD4+ cell counts and 8 reported a decrease , as shown in Table 1. Nine respondents reported an increase in viral load, 10 reported a decrease and 2 patients reported static, Typical individual results were as follows.

Patient A  The initial CD4+ count of 90 cells rose as high as 460 cells (average CD4+ count: 355) in the study period, but viral load was undetected throughout. Previous symptoms were Kaposi’s sarcoma, pneumocystis carinii pneumonia, and allergic conjunctivitis, all of which resolved and remained controlled during study period. The patient consistently reported feeling very well and energy levels much improved.Patient B  The initial CD4+ count of 400 cells rose to 620 cells after the treatment. The viral load of 15,200 copies/ml in CD4+ cells decreased to 5,000 copies/ml. IL-2 production was also increased 3.1 times by Maitake treatment. Previous symptoms were Kaposi’s sarcoma, verrucae, anal warts, anal herpes, diarrhea, chest infections, and fatigue. Following the study period, when the patient received 6 g of Maitake tablets together with 20mg of MD-Fraction per day, Kaposi’s sarcoma became static, verrucae and anal warts were resolved, and other symptoms became intermittent.

Patient C  The initial CD4+ count of 510 cells showed little change at 500 cells after the study, but the viral load of 60,000 copies/ml in CD4+ cell decreased to 1,000 copies/ml. The patient had day and night sweats, bouts of colds, mucous membrane irritation and fatigue as previous symptoms, but after the course of Maitake all symptoms were resolved. In particular, a direct effect on the sweats was observed.Patient D  The initial CD4+ count of 425 rose to 680 counts (average 513.3) during the study. The viral load of 20,000 copies/ml increased to 93,000 copies/ml, but skin, oral, and gastric Candida, catarrh, irritable bowel, and aching muscles as previous symptoms were all improved by Maitake.Patient E  The initial CD4+ count of 17 cells decreased to 7 cells during the study, while the viral load of 55,000 copies/ml increased to 62,000 copies/ml. AIDS, oral Candida, and wasting disease as previous symptoms persisted despite the treatment with Maitake. The CD4+ cell counts and HIV viral loads of other patients who received Maitake for 1 yr are shown in Tables 2 and 3. It is known that long infection period of HIV makes seriously symptoms and secondary disease. Therefore, as shown in Tables 4 and 5, we examined that these symptoms and diseases were improved by Maitake treatment. Symptoms depends on HIV infection, such as weight loss, hair loss, night sweat, fever, dry cough and leg pain, were improved by Maitake almost in 50% of patients (as Table 4), also secondary diseases, such as toxoplasmosis, cryptococcosis, herps, kaposi’s sarcoma and mycopathy, were cured in 40-50% of patients. Table 6 indicates that the percentage of patients reporting changes in symptoms and sense of well-being following treatment.

Discussion ：

The MD-Fraction exhibited an enhancing effect on CD4+ cells, the target cells of HIV, upon oral administration in animals (Hishida et al., 1988). Even though it was a non-controlled trial, this clinical study indicated that MD-Fraction and Maitake powder were effective in patients with breast cancer, lung cancer, or liver cancer. These human tests suggest that the active ingredients of Maitake have significant healing and preventative potential in HIV-responders by stimulating the immune system. The present study indicates that when MD-Fraction and Maitake enhanced the activities of immuno-competent cells such as macrophages, cytotoxic T cells (CD8+) or helper T cell (CD4+), the HIV in CD4+ cells was directly killed or its multiplication was suppressed. However, even if these cellular activities were increased by MD-Fraction, HIV in CD4+ cells of AIDS patients did not decrease. All of the results shown here indicate that there is evidence to support a more structured investigation in to the potential benefits of Maitake and MD-Fraction in the treatment of HIV infection. The results also indicate that this trial study needs to be done on a larger scales, as many questions remain unanswered.

Literature cited：

Hishida I., Nanba H. And Kuroda H. 1988. Anti-tumor activity exhibited by oral administered extract from fruit body of Grifola frondosa (Maitake). Chem. Pharm. Bull. 36:1819-1827.

Nanba H., Hamaguchi A. and Kuroda H. 1987. The chemical structure of an anti-tumorpolysaccharide in fruit bodies of Grifola frondosa (Maitake). Chem. Pharm. Bull. 35: 1162-1168.

Nanba H. and George S. R. 1993. Effects of Maitake (Grifola frondosa) for HIV-positive or fibroid tumor patients. 113th Congr. Pharmaceutical Society of Japan, Osaka, Japan, March 29-31, p.212.

Nanba H.1993. Anti-tumor activity of orally administered D-Fraction from Maitake mushroom Grifola frondosa. J Naturopath. Med. 4: 10-15.

国家有规定，HIV感染者不能做试管婴儿吗?

虽然可以，但是仅限于男性感染HIV情况，女方感染HIV除外。因为对于感染HIV患者而言，若是通过自然妊娠生育，疾病遗传后代可能性大。通过国外（美国，泰国）洗精试管技术，获取高质量精子。也就是说经过检查之后CD4和病载量符合在做试管婴儿的范围，经过洗精之后，筛查健康的胚胎移植，就可以实现好孕优生。

如果女方是HIV携带者：

首先，我们需要了解清楚HIV传播途径当中，较为重要的传播方式——母婴传播。若女方是HIV携带者，进行试管助孕难度比男性大很多。对于这种情况，并不建议女方自己做试管，因为遗传风险非常高。即宝宝大概率会是HIV携带者。

不过办法总比困难多，也非完全没有办法。如果说女方感染HIV，又想生育健康宝宝。可通过第三方的方式。即换个母体或使用第三方的卵子，可保障胎儿免受HIV感染。不过此方案在国内行不通，但是国外政策宽松，可以实现。

感染了HIV能做试管婴儿吗？有哪些医院可以做需要多少钱了？

HIV属于严重的传染性疾病，目前尚且没有完全确保可以阻断传播的方法，而HIV的传播渠道，除了性传播以外，母婴传播亦是主要的一种传播途径，因此HIV属于试管婴儿的禁忌症，夫妻中如果有一方感染了HIV是无法开展试管婴儿治疗的。

目前虽然对于HIV的母婴传播已经研究出了母婴阻断的方法，但是由于对于医疗技术的要求很高，这一技术尚且没有广泛的应用到临床上来，也就无法顺利的应用到试管婴儿的治疗当中，当然相信在将来有关于阻断艾滋传播的医疗技术能够逐渐广泛的应用在临床上来，造福广大的患者。

患有严重传染性疾病是无法做试管婴儿的，除了HIV，常见的还有性传播疾病、乙肝等等，不过性传播疾病、乙肝在经过治疗确保可控制传染给下一代之后，也是可以做试管婴儿的，因此这一类患者如果要备孕，需要先治疗疾病。

浙江医生违规致5人染艾滋案如何宣判？

此前备受社会关注的“浙江省中医院一医生违规操作，致5名患者感染艾滋病”一事近日有最新进展。相关刑事判决书显示，涉事医生在操作过程中严重违反“一人一管一抛弃”的职业规定，致使5人感染了HIV病毒（其中两人已怀孕）。

对此，杭州市上城区人民法院于2017年12月12日判决涉事医生犯医疗事故罪，判处有期徒刑2年6个月。

2017年1月，浙江省中医院被曝“一医生操作不当，致使患者感染艾滋病”一事引发舆论关注。据浙江省卫计委2017年2月9日通报，当年1月26日下午，该委接到浙江省中医院报告，该院一位技术人员在某次技术操作中严重违反规程，该次操作涉及的治疗者可能存在感染艾滋病病毒风险。

事发后，有关部门已对浙江省中医院相关责任人做出严肃处理：免去院长的行政职务和党委副书记职务，给予党内严重警告处分；免去党委书记的党内职务和副院长的行政职务；撤销分管副院长职务，免去其党委委员并给予党内严重警告处分；撤销检验科主任职务；免去医务部主任职务；免去院感科科长职务。直接责任人以涉嫌医疗事故罪由公安机关立案侦查，并已采取刑事强制措施。

鉴于赵金方犯罪后自动投案，并如实供述自己的罪行，有自首情节，且认罪悔罪，可予从轻处罚，对辩护人所提的相应意见予以采纳。但辩护人以赵金方主观上系出于侥幸为由要求从轻的意见，审理认为，正因为医疗事故罪主观方面系由过失构成，刑法规定了相对轻缓的刑罚，再以过失为由要求从轻处罚显然于法无据，故不予支持。

据此，杭州市上城区人民法院于2017年12月12日一审判处被告人赵金方犯医疗事故罪，判处有期徒刑2年6个月。

来源：  北青网

国家卫计委彻查“浙江中医院艾滋感染”事件是怎么回事？

2月3日、12日，李斌先后主持召开专题会议，指出医疗安全关系群众生命健康，容不得半点麻痹疏忽。要本着对人民健康高度负责的态度，高度重视事件处置工作，加强对当地的指导和督促，组织专家细化诊疗方案，尽最大努力减少伤害。对负有责任的单位和人员绝不姑息，依法依规严肃处理和问责。并要求举一反三，正视问题，进一步加强全国医疗机构内部管理，严密制度，狠抓落实，严格规范操作。

具体情况：

国家卫生计生委高度重视浙江省中医院医源性艾滋病病毒感染事件。接报后，国家卫生计生委主任李斌等负责同志立即批示责成当地了解情况，查清原因，对患者迅速进行检测，及时采取应急预防措施，全力进行阻断和诊治，对责任人依法依规严肃处理。

专家认为，事件发生的主要原因是个别医疗机构及医务人员医疗安全意识缺失，医院感染防控管理制度不健全、制度规范落实不力，没有严格遵守技术规范和标准化操作规程开展诊疗工作。应当进一步落实医疗机构主体责任，完善管理机制，加强安全隐患排查，加大全员培训教育力度，切实保障患者健康权益。同时，国家卫生计生委办公厅和国家中医药局办公室分别向全国印发了《关于进一步加强医疗安全管理和风险防范工作的通知》。

2月7日，国家卫生计生委召开由全国各省、市、县三级卫生计生委相关工作负责同志和全国二级以上医院院长参加的视频会议进行部署。要求各级卫生计生行政部门和医疗机构切实提高医疗安全意识，深刻汲取教训，落实医疗安全质量主体责任，加强制度建设，突出管理重点，进一步加强医疗安全管理和风险防范工作。各级卫生计生行政部门和办医主体要切实履行监管职责，建立医疗安全责任追究机制，加大监管工作力度。同时，开展医疗安全专项整顿活动，针对质量、安全和服务中存在的突出问题和薄弱环节，全面整顿质量安全风险并持续改进，切实保障人民群众健康。

关于浙江中医院做试管感染艾滋和浙江试管婴儿hiv感染的介绍到此就结束了，不知道你从中找到你需要的信息了吗 ？如果你还想了解更多这方面的信息可以在线咨询我们。